Risperdal News: Sheller Quoted in Toronto Star
Stephen Sheller was quoted in a July 31, 2015 article discussing Risperdal research that was “manipulated by a drug company and understated the risks of a powerful antipsychotic used to treat kids with behavioural problems.” In the news story, pediatrician Denis Daneman says there was no intent on his part to exclude “significant results” from […]
$1.4 Billion Settlement
Philadelphia Attorney Stephen Sheller’s Whistleblower Clients Help Government Recover $1.4 Billion Record Settlement and Criminal Fine in Eli Lilly & Company Zyprexa® Marketing Case Lead Attorney Filed Complaint in 2003 Representing Six Whistleblowers Pharmaceutical giant Eli Lilly & Company (“Lilly”) agreed to pay federal and state governments more than $1.4 billion in January 2009 to […]
